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Abstract
Inhalation of multi walled carbon nanotubes (MWCNT) causes systemic effects including vascular 
inflammation, endothelial dysfunction, and acute phase protein expression. MWCNTs translocate 
only minimally beyond the lungs, thus cardiovascular effects thereof may be caused by generation 
of secondary biomolecular factors from MWCNT-pulmonary interactions that spill over into the 
systemic circulation. Therefore, we hypothesized that induced matrix metalloproteinase-9 
(MMP-9) is a generator of factors that, in turn, drive vascular effects through ligand-receptor 
interactions with the multiligand pattern recognition receptor, CD36. To test this, wildtype (WT; 
C57BL/6) and MMP-9−/− mice were exposed to varying doses (10 or 40 μg) of MWCNTs via 
oropharyngeal aspiration and serum was collected at 4 and 24 h postexposure. Endothelial cells 
treated with serum from MWCNT-exposed WT mice exhibited significantly reduced nitric oxide 
(NO) generation, as measured by electron paramagnetic resonance, an effect that was independent 
of NO scavenging. Serum from MWCNT-exposed WT mice inhibited acetylcholine (ACh)-
mediated relaxation of aortic rings at both time points. Absence of CD36 on the aortic rings 
(obtained from CD36-deficient mice) abolished the serum-induced impairment of vasorelaxation. 
MWCNT exposure induced MMP-9 protein levels in both bronchoalveolar lavage and whole lung 
lysates. Serum from MMP-9−/− mice exposed to MWCNT did not diminish the magnitude of 
vasorelaxation in naïve WT aortic rings, although a modest right shift of the ACh dose-response 
curve was observed in both MWCNT dose groups relative to controls. In conclusion, pulmonary 
exposure to MWCNT leads to elevated MMP-9 levels and MMP-9-dependent generation of 
circulating bioactive factors that promote endothelial dysfunction and decreased NO 
bioavailability via interaction with vascular CD36.
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Pulmonary exposure to nanomaterials such as carbon nanotubes is associated with the 
progression of cardiovascular disease in vulnerable animal models (Li et al., 2007). 
However, gaps exist in our understanding of the pathways by which inhaled substances 
affect the systemic vasculature, and this hinders our ability to predict risk and identify 
potentially vulnerable subpopulations. Inhaled nanomaterials, such as multiwalled carbon 
nanotubes (MWCNTs), have limited ability to translocate into the systemic circulation 
(Mercer et al., 2013) and evidence for a direct interaction between nanomaterials and 
vascular cells at relevant exposure concentrations is lacking. Several studies have 
demonstrated more profound systemic vascular effects arising from particle inhalation 
(Nurkiewicz et al., 2008, 2009; Sun et al., 2005) as compared with gavage or even direct 
intravenous injection (Bai et al., 2007; Folkmann et al., 2012), suggesting that secondary, 
circulating factors induced by pulmonary responses to exposure contribute to adverse 
cardiovascular effects.
Central to the development of cardiovascular disease is the activation of the endothelium, 
characterized by the increased expression of adhesion molecules, extravasation of 
leukocytes, and the loss of endothelial nitric oxide synthase (eNOS) function (Aird, 2008). 
eNOS produces the diffusible molecule nitric oxide (NO), which is anti-inflammatory, anti-
coagulatory, and vasodilatory (Alheid et al., 1987; Kubes et al., 1991; Nunokawa and 
Tanaka, 1992). In an atherosclerotic state, eNOS becomes “uncoupled” leading to the loss of 
NO bioavailability (Harrison, 1994). Loss of NO enhances the proinflammatory environment 
that is central to the progression of atherosclerosis. Mounting evidence suggests that pattern 
recognition (eg, Toll-like receptor-4, aka TLR4) and/or scavenger receptors (eg, CD36) play 
a prominent role in mediating endothelial activation (Shaul, 2003; Wang et al., 2011). Lipid 
peroxidation products present in the lung lining fluid following exposure to particulate 
matter (PM) mediate systemic cellular inflammatory responses through TLR4, and such 
modified lipids have been shown to be present following exposure to concentrated ambient 
PM (Kampfrath et al., 2011). CD36, a class B scavenger receptor, recognizes many ligands, 
such as thrombospondin and oxidized low density lipoprotein (LDL) cholesterol, and is 
widely expressed on the surface of multiple cell types, including macrophages and 
endothelial cells (Febbraio et al., 1999; Sawada et al., 2012). CD36 is involved in 
atherosclerosis and inflammation (Febbraio et al., 2001) and is required for the endothelial 
dysfunction induced by inhalation to the reactive gas ozone (Robertson et al., 2013).
One potential source of circulating ligands that interact with pattern recognition receptors 
following inhalation exposure is activation of matrix metalloproteinases (MMPs) in the lung 
(Su et al., 2000). MMPs have been shown to be involved in a wide range of process 
including development, wound healing, and host defense (Dagouassat et al., 2012). MMP-9, 
an MMP that binds collagen-based substrates, has been shown to be unregulated and 
activated following exposure to PM and PM-containing combustion mixtures (Lund et al., 
2009, 2011; Su et al., 2000). Erdely et al. (2009) reported increased gene expression of 
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MMP-9 in the lung, as well as an increase in circulating MMP-9 as a result of pulmonary 
MWCNT-7 exposure. The pathophysiological relevance of MMP-9 activation following 
pulmonary exposure to nanomaterials remains unknown.
Currently, no studies exist investigating the potential links between vascular dysfunction, 
MMPs, CD36, and nanomaterial exposure. We hypothesized that MWCNT-7 exposure 
activates MMPs in the lung, leading to the generation of circulating ligands that may directly 
impact vascular function through the CD36 receptor. To test this hypothesis, we applied an 
innovative ex vivo methodology for assessing potential cumulative effects of circulating 
mediators on vascular function. In this study, we demonstrated that MWCNT-7 exposure 
induces the generation of circulating bioactive factors that diminish stimulated NO 




Specific pathogen-free, male C57BL/6J and MMP-9−/− (B6.FVB(Cg)-Mmp9tm1Tvu/J) mice 
from Jackson Laboratory (Bar Harbor, ME) and CD36−/− mice on a C57BL/6 background, 
bred in-house (obtained from Mario Febbraio), were used in this study. C57BL/6J and 
MMP-9−/− mice for exposures were housed in the AAALAC-approved NIOSH Animal 
Facility, while naïve mice (C57BL/6J and CD36−/−) for donating aortas were housed in 
AAALAC-approved facilities at the University of New Mexico. All mice were provided 
food and tap water ad libitum in ventilated cages in a controlled humidity and temperature 
environment with a 12 h light/dark cycle. Animal care and use procedures were conducted in 
accordance with the “PHS Policy on Humane Care and Use of Laboratory Animals” and the 
“Guide for the Care and Use of Laboratory Animals” (NIH publication 86-23, 1996). These 
procedures were approved by the respective Institutional Animal Care and Use Committees 
of the National Institute for Occupational Safety and Health and the University of New 
Mexico.
Mice, 8 weeks of age, were treated via oropharyngeal aspiration with MWCNT (MWNCT-7/
Mitsui-7) at 0, 10, or 40 μg (n = 12 for each group was needed to generate enough serum for 
all tests) in a volume of 50 μl. The MWCNT were prepared in a physiologic dosing media 
(DM) for the vehicle that consisted of mouse serum albumin (0.6 mg/ml) and 1,2-
dipalmitoyl-sn-glyc-ero-3-phosphocholine (10 μg/ml) in phosphate-buffered saline (PBS), 
with sonication for 5 min to ensure dispersion. The MWCNT used in this study, MWCNT-7, 
have been extensively characterized previously (Porter et al., 2010). Mice were euthanized at 
4 and 24 h following pulmonary exposure. Serum was collected and the left lung lobe was 
ligated and removed to preserve for MMP-9 protein determinations. Bronchoalveolar lavage 
(BAL) was performed on the right lung lobes and the first lavage supernatant was assessed 
for lactate dehydrogenase (LDH) activity, albumin concentration, and MMP-9 levels.
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Fractionation and mass spectrometry
Serum was first processed through a 0.1 μm Ultrafree-MC filtration unit (EMDMillipore, 
Billerica, Massachusetts) per manufacturer instructions. The clarified serum (100 μl) was 
then processed through a precleaned Amicon Ultra-0.5 centrifugal filter with Ultracel-30 
membrane (EMDMillipore) per manufacturer instructions at 10 °C. Filtered sera (n = 5 per 
0, 10, 40 μg MWCNT-7 groups) were prepared for liquid chromatography—tandem mass 
spectrometry (LC/MSMS). Samples (32 μl) were acidified with 8 μl of 1% formic acid, with 
4 μl loaded onto a Symmetry C18 reversed-phase trap column using a NanoAcquity UPLC 
(Waters, Milford, Massachusetts). Separation was performed with a 150 mm × 75 μm HSS 
T3 reversed-phase capillary column at 55 °C online with a nanoelectrospray equipped 
Synapt G2 HDMS tandem mass spectrometer (Waters). Separation and data-independent 
mass spectrometric analysis with ion mobility was performed as described previously (Fuller 
et al., 2012; Ottens et al., 2014) with the modifications that gradient elution was performed 
from 2% to 42% acetonitrile in water (formic-acid modified) and spectra were collected 
between 200 and 1800 m/z, with a collisionenergy ramp from 32 to 52 eV. All spectra were 
post-processed employing PLGS ion processing software (Waters). Generated ion tables 
were clustered and aligned by retention time (± 1.0 min), drift time (± 4 bins), and ion mass 
(MH+, ± 12 ppm) using Isoquant software (v1.6 beta) (Distler et al., 2014; Kuharev et al., 
2014). Results were filtered to include only reproducible ion events (observed in 4 or more 
biological replicates per group). Ion mass tables per group were then evaluated and 
compared using histogram analysis with a minimum size of 500 Da.
Cell culture
Mouse cerebrovascular endothelial cells (mCECs) were obtained from a commercial vendor 
(Cell Biologics) and maintained according to manufacturer's recommendations at 37° and 
5% CO2 with complete endothelial cell medium supplemented with 10% Fetal Bovine 
Serum. All experiments were performed between passages 3 and 8. Assays were batched by 
exposure to enhance consistency and comparability across samples.
Spin trapping of MCEC-generated NO using electron paramagnetic resonance
To test the generation of NO, serum from control or MWCNT-7-treated mice (4 h post) was 
added to the mCECs at a ratio of 1:9 (10%) with basal endothelial cell medium. Electron 
paramagnetic resonance (EPR) spectroscopy was conducted according to previously 
described methods with some modifications (Paffett et al., 2015). Following serum 
treatment, mCECs were incubated with the iron-chelate NO-spin trap Fe2+-di(N-methyl-D-
glutaminedithiocarbamate) (Fe2+(MGD)2; 1mM, final concentration) for 5min. The iron-
chelator Fe2+(MGD)2 was freshly prepared by mixing a stock solution of ferrous sulfate 
(FeSO4; 20mM, dissolved in deionized water under N2) and an equal volume of sodium N-
methyl-D-glucamine dithiocarbamate (NaMGD; 100mM, dissolved in deionized water under 
N2) to give a molar ratio of 1:5, respectively, prior to each experiment. Following the 
incubation period, the incubation medium (400 μl) containing spin trapped NO was 
immediately transferred into custom-made gas permeable Teflon tubing (Zeus Industries, 
Raritan, New Jersey), folded 4 times, and inserted into a quartz EPR tube open at each end. 
The quartz EPR tube was inserted within the cavity of a Bruker EleXsys E540 X-band EPR 
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spectrometer (Billerica, Massachusetts) operating at 9.8 GHz and 100 kHz field modulation 
and spectra was recorded after spectrometer tuning at room temperature. The EPR spectrum 
of spin trapped-NO were acquired from untreated mCECs with a scan time of 40 s, and 10 
scans were obtained and averaged to produce significant signal-to-noise ratio. EPR 
measurements from mCECs stimulated with 2mM adenosine triphosphate (ATP) to induce 
NO release were performed under the same conditions. Instrument settings were as follows: 
magnetic field, 3440 G; scan range, 100 G; microwave power, 21 mW; modulation 
frequency, 100 kHz; modulation amplitude, 1.0 G; time constant, 20 ms. The EPR spectra 
were collected, stored, and manipulated using the Bruker Software Xepr (Billerica, 
Massachusetts). NO levels were quantified and peak-to-peak measurements were taken and 
expressed in relative units.mCECs were grown to confluence on 6-well plates and incubated 
for 4 h with 10% serum from MWCNT-exposed mice. Following serum treatment, mCECs 
were incubated with Fe2+(MGD)2. Following application of the trap, a supernatant sample 
was isolated and NO was measured to assess a baseline reading. NO generation at baseline 
was negligible. Endothelial cells were subsequently stimulated with 2 mM ATP for 5 min, 
followed by measurement of NO in a second supernatant sample.
Ex vivo vascular function using myography
Rings from the thoracic aorta were isolated and cleaned of connective tissue. Segments of 
aorta (2 mm length) were mounted in a 4-chamber myograph (610M; Danish Myo 
Technology A/S, Aarhus, Denmark). Vessels were submerged in physiological saline 
solution (composition in millimolar: 119.0 NaCl, 25.0 NaHCO3, 5.5 glucose, 4.7 KCl, 1.2 
MgSO4, 1.2 KH2PO4, 0.025 EDTA, 2.5 CaCl2) bubbled at 37°C with 21% O2–5% CO2 
balance N2 and left to equilibrate for 30 min. Tension was applied in 2 mN stepwise 
increments over 30 min to an optimal passive tension of 9 mN. Preliminary experiments 
showed that this tension produced optimal contraction and relaxation responses. Data from 
force transducers were processed by a MacLab/4e A-DI converter displayed through 
LabChart software (AD Instruments).
Vessel viability was confirmed by a contractile response to the addition of potassium 
containing physiological salt solution (KPSS in millimolar: 64.9 NaCl, 25.0 NaHCO3, 5.5 
glucose, 58.9 KCl, 1.2 MgSO4, 1.2 KH2PO4, 0.025 EDTA, 2.5 CaCl2) repeated twice. 
Aortic rings isolated from naïve C57BL/6J or CD36-null mice were mounted in a myograph 
and challenged twice with KPSS as described above. After a 30-min equilibration period, 
vessels were incubated with 1% serum that was collected from mice exposed to dispersion 
media or MWCNT. Because the addition of serum induced contraction of aortic rings, the 
cumulative concentration-response curves to ACh (10−9 to 10−4) were acquired only after 
the response to serum had stabilized.
Mmp protein levels in lung
Lung lavage fluid and whole lung homogenates were assayed for MMP-2 and MMP-9 
protein concentrations using enzyme-linked immunosorbent assays according to 
manufacturer's instructions (Boster, Pleasanton, California).
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Myographic studies were compared with a 2-way analysis of variance considering exposure 
and acetylcholine (ACh) concentration as the 2 factors, and post hoc comparisons at specific 
ACh concentrations were conducted using Tukey's multiple comparison post hoc testing 
(GraphPad Prism, v 6.0). Other comparisons were conducted with a standard 1-way analysis 
of variance with Dunnett's post hoc test for multiple comparisons.
Results
Multiwalled Carbon Nanotube Exposure Results in Lung Cytotoxicity and Permeability 
Changes
MWCNT-7 used in this study have been previously characterized (Porter et al., 2010). The 
average diameter was 49 nm with a mean length of 3.86 μm (geometric standard deviation = 
1.94; Figs. 1A and B). Purity was >99% carbon. Exposure to MWCNT-7 resulted in a dose-
dependent increase in BAL LDH activity at the 4h time point, which also remained elevated 
at the 24 h time point. The 40 μg dose approximately doubled LDH levels compared with 
controls at both time points, with the 10 μg dose resulting in a 50% increase at both time 
points (Figure 1C). There was no significant difference in albumin levels between groups at 
the 4h time point; however, both the 10 and 40 μg doses showed elevated albumin at the 24 h 
time point when compared with controls (Figure 1D).
Serum From MWCNT-Exposed Mice Decreases Endothelial NO Generation In Vitro
The supernatant of serum-treated endothelial cells, when treated with ATP and the NO spin-
trap MGD, afforded a strong signal detectable by EPR spectroscopy (Figure 2A). Baseline 
measurements of unstimulated endothelial cells resulted in negligible amounts of NO 
production between groups treated with exposed or control serum. In ATP-stimulated cells, 
however, serum from MWCNT-7-exposed mice decreased NO bioavailability by 30% when 
compared with cells incubated with serum from DM control mice (Figure 2B).
These results led us to speculate that the serum from MWCNT-7-exposed mice was able to 
directly affect eNOS or that the serum had the capacity to “scavenge” produced NO. To 
address this question we applied an acellular assay, bypassing the contribution of eNOS. 
MGD in iron-free media was incubated with serum from MWCNT-exposed mice and the 
NO-donor spermine NONOate (1M) as in previous studies with serum from ozone-exposed 
rodents (Paffett et al., 2015). However, serum from MWCNT-7-exposed mice had no effect 
on NO bioavailability when compared with serum from control mice (Figure 2C). These 
results suggested that serum from MWCNT-7-exposed mice diminishes eNOS generation of 
NO, rather than NO bioavailability.
Serum From MWCNT-7-Exposed Mice Diminishes Vasorelaxation Ex Vivo
We next examined the role that MWCNT exposure might have in a functional physiological 
system. We employed force-transduction myography with an isolated aortic ring preparation 
to test the serum bioactivity. Serum from both doses of MWCNT-7-exposed mice was able 
to significantly reduce ACh-induced relaxation (Figure 3). Interestingly, the serum from 10 
μg-treated mice collected 4h postexposure (Figure 3A) was more potent in terms of 
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inhibiting relaxation than was serum from 40 μg-treated mice, with the lower dose reaching 
a maximum relaxation of only 13.6%, compared with 27.1% for the higher dose and 49.4% 
for vehicle controls. This effect persisted at least 24 h postexposure (Figure 3B), although 
more variability was noted. At 24 h post exposure, serum from both low and high dose 
groups similarly inhibited relaxation (26.9% and 28.5%, respectively), as compared with 
DM control serum.
In addition to ACh responses, we assessed whether the initial contraction induced by serum 
treatment was similar between groups. Maximum vessel constriction induced by serumwas 
measured and normalized to a KPSS response. There were no differences between control 
and MWCNT doses at 4h with complete serum (Figure 3A right panel). However, serum 
obtained 24 h following MWCNT exposure did induce a modest but significantly higher 
average constriction in the 40 μg group (101% vs 80% for the low dose and 87% for the 
control; Figure 3B right panel).
Impact of Serum Fractionation on Vasorelaxation Responses
As an initial attempt to understand how serum bioactivity is driven by altered biochemistry 
and to exclude a direct nanomaterial effect on vasorelaxation, the serum was filtered to 
resolve smaller components (<10kDa) for aortic ring treatments. Notably, the filtered serum 
allowed for greater overall relaxation to ACh compared with whole serum, with an average 
relaxation of 77.39% for aortic rings incubated with filtered serum from DM-treated mice. 
In the 4h post-exposure samples, the <10kDa biomolecules induced a prominent anti-
relaxation effect of serum from both doses of MWCNT-7-exposed mice, although the 
specific enhanced potency of the 10 μg dose was no longer observed (Figure 4A). The anti-
relaxant effect of filtered serum components from MWCNT-7-treated mice was largely 
abolished in the 24 h postexposure serum (Figure 4B), suggesting that the <10 kDa 
biomolecules may have complexed with larger biomolecules or that larger biomolecules 
contribute to a persistent effect. There were no differences in initial contraction between 
control and MWCNT doses with 4h filtered serum (removal of large, >10 kDa proteins), or 
with 24 h filtered serum (Figure 4A and B right panels, respectively).
We employed LC/MSMS analysis to confirm that the serum fraction consisted of 
biomolecules below 10 kDa (Figure 4C). Further, in comparing the <10 kDa serum fraction 
between treatment groups, we resolved differences in the mass distribution among doses, 
consistent with the observations of nonlinear dose effects. Importantly, findings with filtered 
sera demonstrate that bioactivity can be induced without any possibility of direct 
nanomaterial or leukocyte interaction with the endothelium.
Vascular CD36 Mediates Endothelial Dysfunction Induced by Serum from MWCNT-7-
Exposed Mice
Aortas harvested from CD36-null mice were employed to determine if the scavenger-
receptor mediated effects of serum from MWCNT-7-exposed mice were similar to previous 
findings with ozone and ambient PM. CD36-null aortic relaxation in response to ACh was 
not impacted by serum from MWCNT-7-exposed mice compared with serum from control 
mice (Figure 5). All 3 groups reached an average maximum relaxation of approximately 
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50% (comparable to wildtype [WT] vessels), with no discernible differences between the 
groups at either time point. These results denote that the bioactive compounds in the serum 
following MWCNT-7 exposure interact with CD36 to impair vasorelaxation.
Interestingly, however, serum from MWCNT-7-exposed mice applied to CD36−/− vessels 
was observed to induce a greater average contraction of 100% for the lower and 104% for 
the higher dose group at the 4h mark compared with aortic rings treated with control serum 
(87%; Figure 5A right panel). By 24 h, the high dose group achieved a contraction of 101%, 
while the low dose was not different from controls (Figure 5B right panel). These findings 
contrast with the vasorelaxation data in that CD36 is not required to induce contraction due 
to MWCNT-induced, serum-borne components.
Serum From MMP-9 Deficient Mice Exhibits Reduced Vascular Bioactivity After MWCNT-7 
Exposure
Lastly, we investigated the potential role of MMP-9 as a source of circulating ligands that 
are generated as a result of MWCNT-7 exposure. MMP-9 levels in WT mice treated with 10 
and 40 μg MWCNT-7 were measured in the lung and BAL at the protein level. MMP-9 was 
up regulated in the BAL at both 10 and 40 μg doses at 4 h, and in the 40 μg dose at 24 h 
(Figure 6A and B). MMP-9 was also significantly upregulated in the lung lysate in the 40 μg 
dose at 24 h (Figure 6D). In contrast, MMP-2 protein levels were unchanged in the lung 
lavage (Supplementary Figure 1).
Building on the finding of MWCNT-7-induced pulmonary MMP-9 expression, MMP-9−/− 
mice were exposed to MWCNT-7 and the bioactivity of the serum was tested for its ability 
to affect eNOS mediated vasorelaxation ex vivo. Deficiency of MMP-9 (Figure 7) appeared 
fully protective relative to WT outcomes (Figure 3). Pulmonary MWCNT-7 cytotoxicity, as 
measured by LDH activity in the bronchoalveolar lavage fluid (BALF), was similar between 
both WT and MMP-9−/− mice (Figure 7A). In both dose groups, WT vessels treated with 
serum from MMP-9−/− mice achieved similar maximal relaxation compared with serum 
from DM-treated MMP-9−/− mice, with an average response of approximately 55% (Figure 
7B). However, the dose-response curve revealed a significant right-shift in both dose groups 
relative to DM-control serum, which suggests that some residual bioactivity may be derived 
outside of MMP-9 activity. DM-control serum from the MMP-9−/− mice was actually more 
permissive of vasorelaxation that WT serum in this ex vivo assay, which further adds to the 
conjecture that MMP-9-derived degradation products may impair vascular function 
(Supplementary Figure 2). Serum-mediated constriction (Figure 7C) was unaltered between 
exposure groups in the MMP-9−/− animals. Collective maximal vasorelaxation outcomes for 
each permutation at the 4-h time point clearly show that pulmonary MWCNT-7 exposure 
leads to bioactivity in the serum that impairs vasorelaxation in a manner dependent on 
MMP-9 to generate the signal and CD36 to respond (Supplementary Figure 3).
Discussion
In this study, we provide functional evidence for a mechanism by which MWCNT-7 exerts 
systemic endothelial dysfunction, which appears to be indirectly mediated by serum-borne 
components. Pulmonary exposure to MWCNT-7 led to the generation of bioactive factors in 
Aragon et al. Page 8













the serum that significantly impaired vascular function ex vivo. Furthermore, the principal 
components of the serum that confer abnormal vasorelaxation act through the vascular CD36 
scavenger receptor and appear, at least acutely (4h), to involve smaller biomolecules 
(<10kDa) released into circulation. The effects of MWCNT-7-induced serum biomolecules 
were not linearly associated with lung burden and may reflect induction of different 
biological responses at different doses. Within this study, we outline a plausible pathway by 
which ligands are derived from MMP-9 activity in the lung, access the circulation and 
interact with vascular CD36 receptors to reduced vasorelaxation. This overarching paradigm 
provides concrete mechanistic detail to theories of pulmonary “spillover” that explain the 
pathogenesis of extrapulmonary effects of inhaled particulates (Brook et al., 2010; Van 
Eeden et al., 2012), although the biological complexity with potentially numerous 
metalloproteinases and pattern recognition receptors involved must be considered. 
Importantly, the observed vascular effects with serum from mice exposed to MWCNT-7 by a 
pulmonary route resolves issues inherent to direct-application nanomaterial research with 
cells or organs, offering an alternative and more anatomically sound (or route-appropriate) 
approach to study mechanisms underlying the extrapulmonary toxicity of inhaled 
particulates.
How serum from MWCNT-7-exposed mice exerts its effects on vascular relaxation 
presumably involves impairment of eNOS and NO generation. Inhalation of pollutants such 
as diesel emissions can lead to uncoupling of eNOS and similar loss of dilatory function 
(Cherng et al., 2011; Knuckles et al., 2008). Nurkiewicz et al. (2009) found that TiO2 
nanoparticles could directly scavenge NO, an effect that was eliminated in the presence of 
antioxidants. We recently observed that serum from ozone-exposed rats exhibited 
diminished serum levels of nitrites and nitrates, and there was some evidence for increased 
nitrosothiol formation in serum, suggesting that NO scavenging may occur (Paffett et al., 
2015). In this study, however, serum from MWCNT-7-exposed mice inhibited aortic 
vasorelaxation and endothelial cell generation of NO, but did not scavenge spermine 
NONOate-donated NO. The outcomes from cell culture and isolated aortic rings suggest that 
a ligand-receptor interaction, and resultant intracellular signaling, mediated a loss of eNOS 
activity, and diminished vasorelaxation.
One potential mechanism to explain how serum from MWCNT-7-exposed mice could 
impair eNOS is through the generation of CD36-interacting ligands, such as oxidized lipids 
or thrombospondin repeat-containing peptides, which have both been shown to impair 
vasorelaxation (Bauer et al., 2010; Matsuda et al., 1993; Silverstein and Febbraio, 2009; 
Uittenbogaard et al., 2000). Specific ligands to CD36 can adversely affect the lipid 
composition of caveole, interfering with eNOS and potentially causing eNOS to become 
uncoupled (Fleming et al., 2005; Shaul, 2003; Wong et al., 2011). The present data, 
combined with recent studies of ozone-induced endothelial dysfunction (Robertson et al., 
2013), implicate an important role for CD36 in mediating the loss of aortic vasorelaxation 
caused by serum from MWCNT-7-treated mice. Notably, vessel relaxation in CD36-null 
aortas was more robust than in WT aortas when treated with control serum. CD36 has been 
implicated as a key inflammatory mediator in response to PM exposure, an important 
component of the macrophage response to oxidized lipids (Rao et al., 2014) and thus may 
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have broader implications for extrapulmonary effects than just endothelial dysfunction 
(Robertson et al., 2013).
We propose that an additional crucial step required for the induction of eNOS-compromising 
bioactivity in serum from MWCNT-7-exposed mice involves the activation of pulmonary 
MMP-9, leading to the generation of protein fragments that can affect biological activity. 
MMP-9 plays a major role in the degradation of extracellular matrix in a large spectrum of 
physiological and pathophysiological process (Bekes et al., 2011). MMP-9 is secreted by a 
wide number of cell types including neutrophils, macrophages, and fibroblasts, creating the 
potential for a large amount of MMP-9 to be generated as a result of lunginjury. Exposures 
to gasoline engine emissions in mice led to system-wide changes in MMP-9 concentrations 
and activity, including induction within atherosclerotic plaques (Lund et al., 2009). 
Furthermore, serum MMP-9 was found to be elevated in both mice and humans exposed to 
diesel emissions (Lund et al., 2009). Pulmonary MMP-9 expression has also been associated 
with vanadium (Colin-Barenque et al., 2008), a vanadium-laden particulate (Su et al., 2000), 
and metal fume (Palmer et al., 2006) exposures. Few studies have examined the 
pathophysiological implications of MMP-9 activity in mediating pulmonary or 
extrapulmonary outcomes of inhaled particulates. Our study found that despite comparable 
acute (4-h) lung injury from MWCNT-7 exposure in WT and MMP-9−/− mice, MMP-9 
deficiency resulted in diminished serum bioactivity after MWCNT-7 treatment compared 
with WT. Interestingly, serum from MMP-9 deficient mice treated with vehicle allowed for 
greater relaxation in aortic rings than did WT serum. MMP-9 has been shown to generate 
numerous vasoactive by-products from the degradation of extracellular matrix proteins, such 
as angiostatin (Cornelius et al., 1998; Pozzi et al., 2000), tumstatin (Hamano et al., 2003), 
and β-dystroglycan (Agrawal et al., 2006). MMP-9 may therefore be responsible for the 
generation of a number of vasoactive agents that help set baseline vascular tone.
Our study highlights the importance of pulmonary nanoparlticle delivery in driving systemic 
vascular effects and the doses used in this study, based on numerous dosimetry analyses, 
represent an extreme but plausible scenario (Erdely et al., 2013). It should be appreciated 
that more pronounced effects were achieved at lower depositions and a 1:100 dilution of 
serum from exposed mice nearly abolished vascular relaxation. Mice have a blood volume of 
approximately 2 ml, depending on their body weight. Even if all of the MWCNT-7 left the 
lungs and stayed in the bloodstream—a gross exaggeration—the MWCNT-7 concentration 
in serum would be approximately 5 μg/ml, which would then be further diluted in the 
vascular bath to a maximal theoretical (yet still improbably high) concentration of 50ng/ml, 
a concentration far below what has been reported to induce endothelial cell toxicity in vitro. 
The rationale for this extreme estimation of dose lies in how pulmonary exposure to 
particulates leads to a clear systemic vascular toxicity that cannot be reproduced with direct 
exposures of particles to the vessels. Furthermore, filtration of serum which would exclude 
molecules >10kDa and certainly any trace of MWCNT-7, did not entirely abrogate vascular 
effects. Studies employing an oral gavage of carbon black were unable to induce substantial 
vascular dysfunction in rats (Folkmann et al., 2012), and studies using an intravenous 
injection of diesel exhaust particles, at similar concentrations to the current MWCNT-7 
doses, in mice were unable to induce vascular dysfunction (Bai and van Eeden, 2013). The 
lack of biological effect in these alternate exposure routes serves to highlight the importance 
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of the pulmonary exposure in the pathogenesis of vascular outcomes. It should be further 
noted that occupational exposure to carbon nanotubes at typical concentrations 
(approximately 10 μg/m3) would require 19 years of exposure (5 days/week) in humans to 
achieve the proportional lung burden in our lowest concentration (Erdely et al., 2013). While 
the present study is primarily designed to address the underlying pathways leading to 
systemic vascular effects following pulmonary exposures, it must be clear that safety 
assessment at these concentrations in vivo, and even more so in vitro, require thoughtful 
consideration of the extrapolation to relevant doses.
In conclusion, serum obtained from mice exposed to MWCNT-7 has the capacity to impair 
vasorelaxation in naïve aortic rings ex vivo, an effect that persisted at least 24 h after 
exposure. Notably, the low dose of 10 μg induced even greater serum bioactivity at the 4-h 
time point than did the 40 μg dose, which we believe may be related to a discordance in the 
profiles of circulating factors generated by varying doses. Results from the present study 
further highlight the role of smaller, <10 kDa biomolecules, in addition to larger species, 
which appear to be generated by MMP-9 and may collectively act through the scavenger 
receptor CD36 to reduce responsiveness to ACh. These data further support the concept that 
pulmonary reactions lead to a spillover of secondary mediators from the lungs into the 
systemic circulation. Future work will need to further elucidate, via fractionation studies, 
which portions/components of the serum exhibit biological activity, as well as peptide 
sequencing to provide further insight into the enzymatic origins of the circulating peptides. 
Additionally, the use of serum from exposed mice in ex vivo assays offers a novel, more 
anatomically sophisticated and even translational approach for studying the systemic impact 
of inhaled substances.
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A and B, MWCNT-7 imaging by electron microscopy demonstrates the relative size and 
adequacy of dispersion. C and D, Markers of injury in the lung lavage, LDH and albumin 
levels, were increased following exposure (*P < .05 vs DM by ANOVA, N=4–8 per group). 
MWCNT: multiwalled carbon nanotubes.
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Effects of serum from MWCNT-7-exposed mice on NO generation and bioavailabilty. A, 
Representative EPR spectra from endothelial cells incubated with control serum and serum 
from MWCNT-7-exposed mice. B, Unstimulated endothelial cells exhibited minimal 
baseline levels of detectable NO, which was not different when incubated with serum from 
DM (control) or MWCNT-7-treated mice. However, when stimulated by ATP, endothelial 
cells incubated with control serum demonstrated a significantly greater capacity to generate 
NO than cells treated with serum from MWCNT-7-exposed mice (*P < .05, N=3 per group). 
C, In an acellular assay, levels of NO in iron-free media containing a known concentration of 
the NO donor, spermine NONOate, were not different in the presence of serum from control 
or MWCNT-7-treated mice. NO: nitric oxide; EPR: electron paramagnetic resonance.
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A, Mouse serum obtained 4h following MWCNT-7 treatment inhibited ACh-mediated 
vasorelaxation in aortic rings from untreated (naïve) mice (left) and maximum vessel 
constriction induced by serum (normalized to a KPSS response; right). Interestingly, the 
serum from low dose-treated mice was more potent than serum from high dose-treated mice. 
Asterisks indicates significant difference from control by 2-way ANOVA with Tukey's 
multiple comparison test (*P < .05, **P < .001), dagger represents significant difference 
between the 10 and 40 µg doses (†P < .01; N = 10 per group). B, Mouse serum obtained 24h 
following MWCNT-7 treatment inhibited ACh-mediated vasorelaxation in aortic rings from 
untreated (naïve) mice (left), however the increased potency of the low dose exposure at 4h 
was no longer observed. Maximum vessel constriction induced by serum (normalized to a 
KPSS response) is also shown (right of each relaxation curve). *Indicates significant 
difference from DM control by 2-way ANOVA (*P < .05, **P < .01; N = 6–8 per group). 
Ach: acetylcholine; KPSS: potassium containing physiological salt solution.
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A, Mouse serum obtained 4h following MWCNT-7 treatment was filtered to remove all 
larger proteins, leaving only biomolecules <10 kDa. This filtered serum still inhibited ACh-
mediated vasorelaxation in aortic rings from untreated (naïve) mice. Asterisks indicate 
significant difference from control by 2-way ANOVA with Tukey's multiple comparison test 
(*P < 0.05, **P < .01; N = 5 per group). B, Filtered mouse serum obtained 24 h following 
MWCNT-7 treatment did not affect ACh-mediated vasorelaxation in aortic rings from 
untreated mice (N = 5 per group). C, Mass spectroscopic analysis of numerous biomolecules 
ranging from 0.5 to 10 kDa remaining after filtration confirms the removal of large 
molecules in this bioactive fraction. Individual peaks are collected into bins of the histogram 
and separated by dose group for the 4h posttreatment serum.
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A, Mouse serum obtained 4h following MWCNT-7 treatment had no effect on ACh-
mediated vasorelaxation in aortic rings from untreated CD36-null mice (N = 5 per group). 
Significant differences in the contractile response to the serum addition were noted for 
serum from MWCNT-7-treated mice. Asterisks indicate significant difference from control 
by ANOVA with Dunnett's multiple comparison test (*P <.05; n = 5 per group). B, Filtered 
mouse serum obtained 24h following MWCNT-7 treatment had no effect on ACh-mediated 
vasorelaxation in aortic rings from untreated CD36-null mice (N = 4–5 per group). 
Significant differences in the contractile response to the serum addition were noted for 
serum from the 40 μg MWCNT-7-treated mice. Asterisks indicate significant difference 
from control by ANOVA with Dunnett's multiple comparison test (*P < .05; n = 5 per 
group).
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MMP-9 protein levels in bronchoalveolar lavage (A and B) and whole lung lysates (C and 
D) from MWCNT-7-exposed mice. Asterisks indicate significant difference from control by 
ANOVA with Dunnett's multiple comparison test (*P < .05; **P < .01).
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A, MMP-9−/− mice exhibit similar degree of lung injury at 4h post MWCNT-7 aspiration, as 
measured by LDH from the BALF. Asterisks indicate significant difference from control by 
2-way ANOVA with Tukey's multiple comparison test (*P < .01; **P < .001). B, Serum 
from MMP-9−/− mice treated with 10 or 40 μg MWCNT-7 caused a modest right-shift effect 
on the concentration response to ACh-mediated vasorelaxation in WT vessels, compared 
with serum from the DM control mice, but did not reduce the overall magnitude of 
relaxation. Serum from the various groups exhibited a consistent contractile effect on all 
aortas. Asterisks indicate significant difference from control by 2-way ANOVA with Tukey's 
multiple comparison test (*P < .05; n = 5–6 per group).WT: wild type; MMP-9: matrix 
metalloproteinase-9; DM. dosing media.
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